Loading clinical trials...
Loading clinical trials...
The goal of this pilot is to reduce the 30-day hospital readmission rate for dialysis patients. It is a quality improvement project that consistent of 4 "tracks." Tracks 1 \& 2: Implement use of check...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Fresenius Medical Care North America
Collaborators
NCT04634916 · Kidney Disease, End-Stage, End-stage Renal Disease, and more
NCT06326905 · Quality of Life, Depression, and more
NCT07157397 · End Stage Renal Disease (ESRD), End Stage Kidney Disease (ESRD), and more
NCT07020832 · Delayed Graft Function, End Stage Renal Disease, and more
NCT07153939 · Chronic Kidney Disease, Hemodialysis Access, and more
Fresenius
Franklin, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions